DermaRite Industries recalled several hand soaps in the US and Puerto Rico. The soaps contain Burkholderia cepacia germ. This germ can caus...

Donald Trump's judicial picks show anti-abortion leanings. Many have defended abortion restrictions. Some even have ties to anti-abortion g...

Marty Makary has been picked by Donald Trump to lead the Food and Drug Administration, which is responsible for regulating products ranging...

Days after claiming a resounding victory in US elections 2024, Donald Trump has announced he will nominate investor Scott Bessent for Treas...

Robert F. Kennedy Jr., nominated by President Donald Trump for U.S. Health Secretary, has secured enough votes from senators for confirmati...

Robert F. Kennedy Jr.'s grilling by the Senate Finance Committee comes amid a flurry of campaigns and letters from doctors, patient advocac...

Donald Trump's transition team plans to withdraw the U.S. from the World Health Organization on the first day of his second term, citing th...

Donald Trump's second tenure as the US President begins on January 20, 2025. All eyes are on his big announcements after taking charge of W...

President-elect Donald Trump has nominated Dr. Jay Bhattacharya, a Stanford professor, to lead the National Institutes of Health (NIH). Bha...

US President-elect Donald Trump has started unveiling names for high-profile positions in his cabinet.

President-elect Donald Trump has selected Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human Se...

Donald Trump appointed Robert F. Kennedy Jr. as head of the Department of Health and Human Services. Kennedy, an environmental activist, pl...

Vivek Ramaswamy, 37, whose parents migrated to the United States from Kerala and worked at a General Electric plant in Ohio, made the annou...

Biden is expected to announce his choice for HHS secretary next week. That person has to have ``the confidence of the president, the abilit...

MSCI's broadest index of Asia-Pacific shares outside of Japan was last down 0.04%, but not too far from a six-month high touched last week.

Pharma basket should be an outperformer as a proxy to a weak rupee and better generic pricing in 2019.

The concern that ECB may unwind its easy monetary policy and potential supply limits by oil producing countries could contribute to market ...